EUVIMEDEUVIMED entdecken
Crossref

Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis

Ankit Kumar Meena, Pamali Mahasweta Nanda, Rajni Sharma iD, Biswaroop Chakrabarty, Sheffali Gulati

Indian Journal of Pediatrics · 2024

DOI: 10.1007/s12098-023-04472-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pediatrics, 2024. Verfasst von Ankit Kumar Meena und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Inappropriate ADH Syndrome, Hyponatremia, Heart Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is one of the common causes of euvolemic hyponatremia (serum Na+ < 135 mEq/L) in hospitalized children. It is characterized by increased serum ADH, leading to water retention via its action on V2 receptors in the distal renal tubules. Various conditions such as pain, the postoperative state, drugs, central nervous system infections, tumors, malformations, and pneumonia can predispose a person to SIADH. The conventional treatment of SIADH includes fluid restriction and salt supplementation. Occasionally, this may fail to control hyponatremia, mandating pharmacological therapy. V2-receptor antagonists are an FDA-approved therapy for adults with euvolemic and hypervolemic hyponatremia. However, there is limited experience with their use in the pediatric population. Here, the authors present a girl with corpus callosum agenesis with severe symptomatic hyponatremia due to SIADH who was successfully managed with the V2-receptor antagonist tolvaptan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inappropriate ADH SyndromeHyponatremiaHeart FailureAdultFemaleChildHumansTolvaptanAgenesis of Corpus CallosumAntidiuretic Hormone Receptor AntagonistsVasopressins

Stichwörter der Autor:innen

Antidiuretic hormoneHyponatremiaSyndrome of inappropriate antidiuretic hormone secretionV2-receptor antagonists

Substanzen

TolvaptanAntidiuretic Hormone Receptor AntagonistsVasopressins

Autor:innen und Institutionen

  • Division of Pediatric Neurology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
  • Division of Pediatric Endocrinology, Department of Pediatrics, All India Institute of Medical Sciences, Room No. 3058, Teaching Block, New Delhi, 110029, India.
  • Division of Pediatric Endocrinology, Department of Pediatrics, All India Institute of Medical Sciences, Room No. 3058, Teaching Block, New Delhi, 110029, India. drrajnisharma@yahoo.com.

ORCID-Profile: Rajni Sharma

Zitieren

APA

Meena, A. K., Nanda, P. M., Sharma, R., Chakrabarty, B., & Gulati, S. (2024). Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis. Indian Journal of Pediatrics. https://doi.org/10.1007/s12098-023-04472-5

Vancouver

Meena AK, Nanda PM, Sharma R, Chakrabarty B, Gulati S. Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis. Indian Journal of Pediatrics. 2024. doi:10.1007/s12098-023-04472-5

BibTeX
@article{Meena2024,
  author = {Meena, Ankit Kumar and Nanda, Pamali Mahasweta and Sharma, Rajni and Chakrabarty, Biswaroop and Gulati, Sheffali},
  title = {Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis},
  journal = {Indian Journal of Pediatrics},
  year = {2024},
  doi = {10.1007/s12098-023-04472-5}
}
Kostenlos starten →